Covid19, Fatigue
Conditions
Keywords
essential oils, aromatherapy, energy
Brief summary
The purpose of this study is to assess the efficacy of plant based aromas on energy levels among otherwise healthy female survivors of COVID-19.
Detailed description
After being informed about the study, participants will provide informed consent, then will be randomized into one of two groups in a 1:1 ratio. Participants will either inhale an inert blend twice a day or an active aroma twice a day for 14 days.
Interventions
OTHERAromatherapy
The aromatherapy intervention consists of inhaling a fragrant oil extracted from citrus peels, plant resins, and leaves.
OTHERPlacebo
The placebo intervention consists of inhaling an oil extracted from inert plant matter.
Sponsors
Young Living Essential Oils
Nutraceuticals Research Institute
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
19 Years to 49 Years
Healthy volunteers
Yes
Inclusion criteria
* Age 19-49 * Lives in the United States * Otherwise Healthy * COVID-19 Diagnosis between December 1, 2020 and March 31, 2021 * Decreased energy or fatigue at a level that was not present prior to the diagnosis
Exclusion criteria
* Positive COVID-19 test any time before December 1, 2020 * Positive COVID-19 test any time after March 31, 2021 * COVID vaccine of any type scheduled during the intervention period or the week prior to the start of the study * Allergy to any of the ingredients * Pregnant, trying to conceive, or breastfeeding * Regular smokers in the home * Abnormal pulmonary function * Chest pain * Recurring headaches * Uncontrolled hypertension * Chronic Fatigue Syndrome diagnosis * Persistent fatigue prior to COVID-19 diagnosis * Hypothyroidism
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline on the Multidimensional Fatigue Symptom Inventory (MFSI) at day 14. | Baseline and Day 14 | The MFSI is a validated, 83 question scale measuring fatigue levels across ten domains. Each question is scored from 0-5 on a Likert scale, with higher scores indicating higher levels of fatigue. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline to day 14 on the Patient Health Questionnaire (PHQ-9) | Baseline and Day 14 | This survey includes 9 questions regarding levels of depression. Each question is scored from 0-3 on a Likert scale, with higher scores indicating higher levels of depression. |
Countries
United States
Outcome results
None listed